Institutional investors purchased a net $361.3 thousand shares of SPPI during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 73.66% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DIMENSIONAL FUND ADVISORS LP Bought 463.4 Thousand shares of Spectrum Pharmaceuticals ...